propofol · Fresenius Kabi Usa · NDA 019627
Diprivan
Earliest generic entry, as listed
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- Generic approved · ANDA 217945, Emerge Bioscience · 019627-002Approved 2 Dec 2025Detected 25 Oct 2026Historical import
- Generic approved · ANDA 220857, Adaptis · 019627-002Approved 14 Jul 2026Detected 25 Oct 2026Historical import
Products covered · 2
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 019627 · 001 · discontinued | injectable, injection | 10MG/ML | open |
| 019627 · 002 · RLD | injectable, injection | 10MG/ML | open |